NasdaqCM - Nasdaq Real Time Price USD

Tenon Medical, Inc. (TNON)

Compare
3.9300 +0.6700 (+20.55%)
At close: October 31 at 4:00 PM EDT
3.6801 -0.25 (-6.36%)
After hours: October 31 at 7:59 PM EDT
Loading Chart for TNON
DELL
  • Previous Close 3.2600
  • Open 3.8200
  • Bid 2.9200 x 200
  • Ask 4.5500 x 200
  • Day's Range 3.5507 - 4.1200
  • 52 Week Range 2.8000 - 37.6000
  • Volume 20,789,849
  • Avg. Volume 2,517,931
  • Market Cap (intraday) 2.221M
  • Beta (5Y Monthly) 2.19
  • PE Ratio (TTM) --
  • EPS (TTM) -26.6400
  • Earnings Date Nov 13, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 22.00

Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.

www.tenonmed.com

21

Full Time Employees

December 31

Fiscal Year Ends

Recent News: TNON

View More

Performance Overview: TNON

Trailing total returns as of 10/31/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

TNON
68.91%
S&P 500
19.62%

1-Year Return

TNON
63.88%
S&P 500
36.93%

3-Year Return

TNON
99.78%
S&P 500
36.36%

5-Year Return

TNON
99.78%
S&P 500
36.36%

Compare To: TNON

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: TNON

View More

Valuation Measures

Annual
As of 10/31/2024
  • Market Cap

    2.23M

  • Enterprise Value

    4.12M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.42

  • Price/Book (mrq)

    9.00

  • Enterprise Value/Revenue

    1.22

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -109.52%

  • Return on Equity (ttm)

    -1,598.62%

  • Revenue (ttm)

    3.37M

  • Net Income Avi to Common (ttm)

    -13.87M

  • Diluted EPS (ttm)

    -26.6400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.97M

  • Total Debt/Equity (mrq)

    67.43%

  • Levered Free Cash Flow (ttm)

    -8.35M

Research Analysis: TNON

View More

Company Insights: TNON

Research Reports: TNON

View More

People Also Watch